These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2498594)

  • 21. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 25. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 26. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages].
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary drug resistance of tuberculosis mycobacteria].
    Fedotova ZN; Kerpel' RS
    Probl Tuberk; 1971; 49(11):33-7. PubMed ID: 5004856
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dynamics of the frequency of development of drug resistance in the causative agent of tuberculosis and its effect on the efficacy of treatment of patients with pulmonary tuberculosis].
    Abramovskaia AK; Antipova SI
    Probl Tuberk; 1988; (10):24-7. PubMed ID: 3148132
    [No Abstract]   [Full Text] [Related]  

  • 29. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 30. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mycobacterial resistance/found in the province of Matera (observations in the 4-year period, 1977-1980)].
    Buono L; Mazzarone R
    Arch Monaldi; 1981; 36(3):131-40. PubMed ID: 6816184
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience in treating tuberculosis patients in the IB outpatient registry group].
    Smirnov GA; Valitova ZIu; Fattakhova RM; Anastas'ev VS
    Probl Tuberk; 1986; (4):12-5. PubMed ID: 3086863
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical manifestations and treatment of respiratory organ tuberculosis in children caused by Mycobacterium bovis].
    Niiazbekova KZh
    Probl Tuberk; 1985; (4):28-31. PubMed ID: 3923470
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary resistance to the major anti-tuberculosis drugs in Ethiopia.
    Wolde K; Lemma E; Abdi A
    Ethiop Med J; 1986 Jan; 24(1):15-8. PubMed ID: 3080312
    [No Abstract]   [Full Text] [Related]  

  • 37. [The Mycobacteria Working Group: Investigation of resistance of tuberculosis bacteria in Germany 1991 and 1992].
    Urbanczik R
    Pneumologie; 1994 Jan; 48(1):28-9. PubMed ID: 8153116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
    Marsenić B; Panajotović H
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():60-7. PubMed ID: 4216923
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tuberculosis chemotherapy in cases of resistance].
    Troi K; Marcocci S
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():477-8. PubMed ID: 6417641
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI; Gur'ian IE
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.